Whether the large effect size of endovascular thrombectomy (EVT) for stroke due to large-vessel occlusion applies to stroke due to medium-vessel occlusion is unclear. In a multicenter, prospective ...

Few procedures have gone through a decade of practice-changing clinical trials as impressive as thrombectomy for stroke. Beginning in 2015 with multiple trials showing a benefit with thrombectomy ...

Obinutuzumab, a humanized type II anti-CD20 monoclonal antibody, provided significantly better renal responses than placebo in a phase 2 trial involving patients with lupus nephritis receiving ...

Familial HLH is a success story in modern medicine. Initially a disease that ... to be 4.2 cases per 1 million population in 2018 in England. 15 The annual incidence of HLH associated with cancer ...

Endovascular treatment (EVT) of stroke with large-vessel occlusion is known to be safe and effective. The effect of EVT for occlusion of medium or distal vessels is unclear. We randomly assigned ...

If there were any doubts about Chris Olave, then he put them to bed recently. NOLA.com's Rashad Milligan caught up with the New Orleans Saints receiver recently and passed along a very positive ...

Former England Rugby captain Chris Robshaw discusses England’s defeat to Ireland ... If you look at the likes of Tommy Freeman and Freddie Steward, they are so good in the air and the new kicking ...

Nicola Twilley on the quest for artificial blood. Plus: how the Oscar race got as messy as “Conclave”; the U.S.-Soviet search ...

The Bank of England cut its key interest rate Thursday, a response to a troubling mix of stuttering economic growth, stubborn inflation and President Trump’s tariff threats. The BOE cut rates ...

Researchers discovered a previously unknown mechanism that may drive tissue damage and a new target for drug discovery.

Mubi has unveiled a new clip from “Bring Them Down,” starring Oscar nominee Barry Keoghan (“Saltburn”) and Christopher Abbott (“Poor Things”), ahead of its Feb. 7 theatrical release in ...

Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.